腹膜透析相关性腹膜纤维化有关机制研究进展
Research Progress on the Mechanism of Peritoneal Fibrosis Related to Peritoneal Dialysis
DOI: 10.12677/ACM.2022.123317, PDF,   
作者: 杨 雨*, 翟文娟, 杨照玉, 李欣绪, 王加如, 籍文捷：山东第一医科大学，山东 济南；张宏涛：锦州医科大学，辽宁 锦州；王志奎#：临沂市人民医院，山东 临沂
关键词: 腹膜透析；腹膜纤维化；TGF-β；miRNA；lncRNA；Peritoneal Fibrosis； Peritoneal Fibrosis； TGF-β； miRNA； lncRNA
摘要: 腹膜透析患者发生腹膜纤维化会使腹膜的弥散、对流、超滤功能进行性衰退，最终发生超滤衰竭。腹膜纤维化是尿毒症患者长时间腹膜透析治疗后被迫中止腹膜透析最重要的原因。本文主要对腹膜透析相关性腹膜纤维化中TGF-β介导的信号通路、miRNA和lncRNA在腹膜纤维化调控机制中的研究进展作一综述。
Abstract: Peritoneal fibrosis in peritoneal dialysis patients will progressively decline the diffusion, convection, and ultrafiltration functions of the peritoneum, and eventually lead to ultrafiltration failure. And it is the most important reason for forced discontinuation of peritoneal dialysis in uremic patients after prolonged peritoneal dialysis treatment. This article mainly reviews the research progress of TGF-β-mediated signaling pathway, miRNA and lncRNA in the regulation mechanism of peritoneal fibrosis related to the peritoneal dialysis.
文章引用：杨雨, 翟文娟, 张宏涛, 杨照玉, 李欣绪, 王加如, 籍文捷, 王志奎. 腹膜透析相关性腹膜纤维化有关机制研究进展[J]. 临床医学进展, 2022, 12(3): 2201-2210. https://doi.org/10.12677/ACM.2022.123317

参考文献

[1] Purnell, T.S., Auguste, P., Crews, D.C., et al. (2013) Comparison of Life Participation Activities among Adults Treated by Hemodialysis, Peritoneal Dialysis, and Kidney Transplantation: A Systematic Review. American Journal of Kidney Diseases, 62, 953-973. [Google Scholar] [CrossRef] [PubMed]
[2] 陈勇. 血液透析和腹膜透析患者生存率与生活质量对比分析[J]. 国际医药卫生导报, 2019(9): 1483-1485.
[3] 邹庚艺, 曹雪莹, 周建辉, 等. 腹膜透析相关腹膜纤维化的防治进展[J]. 中华肾病研究电子杂志, 2016, 5(1): 42-44.
[4] Van Baal, J.O., Van De Vijver, K.K., Nieuwland, R., et al. (2017) The Histophysiology and Pathophysiology of the Peritoneum. Tissue Cell, 49, 95-105. [Google Scholar] [CrossRef] [PubMed]
[5] Mutsaers, S.E. and Wilkosz, S. (2007) Structure and Function of Mesothelial Cells. Cancer Treatment and Research, 134, 1-19. [Google Scholar] [CrossRef] [PubMed]
[6] Yurchenco, P.D. (2011) Basement Membranes: Cell Scaffoldings and Signaling Platforms. Cold Spring Harbor Perspectives in Biology, 3, a004911. [Google Scholar] [CrossRef] [PubMed]
[7] Di Paolo, N. and Sacchi, G. (2000) Atlas of Peritoneal Histology. Peritoneal Dialysis International, 20, S5-S96.
[8] Tawada, M., Ito, Y., Hamada, C., et al. (2016) Vascular Endothelial Cell Injury Is an Important Factor in the Development of Encapsulating Peritoneal Sclerosis in Long-Term Peritoneal Dialysis Patients. PLoS ONE, 11, e0154644. [Google Scholar] [CrossRef] [PubMed]
[9] Garosi, G. and Di Paolo, N. (2000) Peritoneal Sclerosis: One or Two Nosological Entities? Seminars in Dialysis, 13, 297-308. [Google Scholar] [CrossRef] [PubMed]
[10] Yáñez-Mó, M., Lara-Pezzi, E., Selgas, R., et al. (2003) Peritoneal Dialysis and Epithelial-to-Mesenchymal Transition of Mesothelial Cells. The New England Journal of Medicine, 348, 403-413. [Google Scholar] [CrossRef] 
[11] Witowski, J., Kawka, E., Rudolf, A., et al. (2015) New Developments in Peritoneal Fibroblast Biology: Implications for Inflammation and Fibrosis in Peritoneal Dialysis. BioMed Research International, 2015, Article ID: 134708. [Google Scholar] [CrossRef] [PubMed]
[12] Aroeira, L.S., Aguilera, A., Sánchez-Tomero, J.A., et al. (2007) Epithelial to Mesenchymal Transition and Peritoneal Membrane Failure in Peritoneal Dialysis Patients: Pathologic Significance and Potential Therapeutic Interventions. Journal of the American Society of Nephrology, 18, 2004-2013. [Google Scholar] [CrossRef] 
[13] Tawada, M., Ito, Y., Banshodani, M., et al. (2021) Vasculopathy Plays an Important Role during the Development and Relapse of Encapsulating Peritoneal Sclerosis with Conventional Peritoneal Dialysis Solutions. Nephrology Dialysis Transplantation, 36, 1519-1526. [Google Scholar] [CrossRef] [PubMed]
[14] 李双喜. CKAP4在腹膜透析腹膜纤维化中的作用机制及临床应用[D]: [博士学位论文]. 重庆: 中国人民解放军海军军医大学, 2021.
[15] 童孟立. 腹膜透析患者腹膜纤维化发生机制及防治的研究进展[J]. 浙江医学, 2020, 42(6): 529-532.
[16] 张倩, 孙丽娜, 聂春迎, 等. 腹膜透析相关性腹膜纤维化发生机制[J]. 中国中西医结合肾病杂志, 2019, 20(3): 265-267.
[17] Xu, X., Zheng, L., Yuan, Q., et al. (2018) Transforming Growth Factor-β in Stem Cells and Tissue Homeostasis. Bone Research, 6, 2. [Google Scholar] [CrossRef] [PubMed]
[18] Gui, T., Sun, Y., Shimokado, A., et al. (2012) The Roles of Mitogen-Activated Protein Kinase Pathways in TGF-β-Induced Epithelial-Mesenchymal Transition. Journal of Signal Transduction, 2012, Article ID: 289243. [Google Scholar] [CrossRef] [PubMed]
[19] Stewart, A.G., Thomas, B. and Koff, J. (2018) TGF-β: Master Regulator of Inflammation and Fibrosis. Respirology, 23, 1096-1097. [Google Scholar] [CrossRef] [PubMed]
[20] Meng, X.M., Nikolic-Paterson, D.J. and Lan, H.Y. (2016) TGF-β: The Master Regulator of Fibrosis. Nature Reviews Nephrology, 12, 325-338. [Google Scholar] [CrossRef] [PubMed]
[21] 林文珊, 周添标. 腹膜透析相关性腹膜纤维化发生机制及治疗新进展[J]. 实用医学杂志, 2019, 35(3): 4-9.
[22] Duan, W.J., Yu, X., Huang, X.R., et al. (2014) Opposing Roles for Smad2 and Smad3 in Peritoneal Fibrosis in Vivo and in Vitro. The American Journal of Pathology, 184, 2275-2284. [Google Scholar] [CrossRef] [PubMed]
[23] 张露. 黄芪甲苷干预腹膜间皮细胞表型转化的分子机制研究[D]: [博士学位论文]. 南京: 南京中医药大学, 2017.
[24] Silva, F.M.O., Costalonga, E.C., Silva, C., et al. (2019) Tamoxifen and Bone Morphogenic Protein-7 Modulate Fibrosis and Inflammation in the Peritoneal Fibrosis Model Developed in Uremic Rats. Molecular Medicine, 25, 41. [Google Scholar] [CrossRef] [PubMed]
[25] Zhang, Y., Huang, Q., Chen, Y., et al. (2020) Parthenolide, an NF-κB Inhibitor, Alleviates Peritoneal Fibrosis by Suppressing the TGF-β/Smad Pathway. International Immunopharmacology, 78, Article ID: 106064. [Google Scholar] [CrossRef] [PubMed]
[26] Zuo, W. and Chen, Y.G. (2009) Specific Activation of Mitogen-Activated Protein Kinase by Transforming Growth Factor-Beta Receptors in Lipid Rafts Is Required for Epithelial Cell Plasticity. Molecular Biology of the Cell, 20, 1020-1029. [Google Scholar] [CrossRef] [PubMed]
[27] Derynck, R. and Budi, E.H. (2019) Specificity, Versatility, and Control of TGF-β Family Signaling. Science Signaling, 12, eaav5183. [Google Scholar] [CrossRef] [PubMed]
[28] Lee, M.K., Pardoux, C., Hall, M.C., et al. (2007) TGF-beta Activates Erk MAP Kinase Signalling through Direct Phosphorylation of ShcA. Embo Journal, 26, 3957-3967. [Google Scholar] [CrossRef] [PubMed]
[29] Strippoli, R., Benedicto, I., Pérez Lozano, M.L., et al. (2008) Epithelial-to-Mesenchymal Transition of Peritoneal Mesothelial Cells Is Regulated by an ERK/NF-kappaB/Snail1 Pathway. Disease Models & Mechanisms, 1, 264-274. [Google Scholar] [CrossRef] [PubMed]
[30] Strippoli, R., Loureiro, J., Moreno, V., et al. (2015) Caveolin-1 Deficiency Induces a MEK-ERK1/2-Snail-1-Dependent Epithelial-Mesenchymal Transition and Fibrosis during Peritoneal Dialysis. EMBO Molecular Medicine, 7, 357. [Google Scholar] [CrossRef] [PubMed]
[31] Shang, J., He, Q., Chen, Y., et al. (2019) miR-15a-5p Suppresses Inflammation and Fibrosis of Peritoneal Mesothelial Cells Induced by Peritoneal Dialysis via Targeting VEGFA. Journal of Cellular Physiology, 234, 9746-9755. [Google Scholar] [CrossRef] [PubMed]
[32] Strippoli, R., Benedicto, I., Foronda, M., et al. (2010) p38 Maintains E-Cadherin Expression by Modulating TAK1-NF-kappa B during Epithelial-to-Mesenchymal Transition. Journal of Cell Science, 123, 4321-4331. [Google Scholar] [CrossRef] [PubMed]
[33] Lupinacci, S., Perri, A., Toteda, G., et al. (2019) Olive Leaf Extract Counteracts Epithelial to Mesenchymal Transition Process Induced by Peritoneal Dialysis, through the Inhibition of TGFβ1 Signaling. Cell Biology and Toxicology, 35, 95-109. [Google Scholar] [CrossRef] [PubMed]
[34] Strippoli, R., Moreno-Vicente, R., Battistelli, C., et al. (2016) Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis. Stem Cells International, 2016, Article ID: 3543678. [Google Scholar] [CrossRef] [PubMed]
[35] Patel, P., Sekiguchi, Y., Oh, K.H., et al. (2010) Smad3-Dependent and -Independent Pathways Are Involved in Peritoneal Membrane Injury. Kidney International, 77, 319-328. [Google Scholar] [CrossRef] [PubMed]
[36] 樊敏, 刘伏友, 段绍斌, 等. PI3K/AKT信号通路在TGFβ1致人腹膜间皮细胞转分化中的作用[J]. 中国现代医学杂志, 2010, 20(5): 672-675.
[37] Guo, Y., Wang, L., Gou, R., et al. (2020) Noncoding RNAs in Peritoneal Fibrosis: Background, Mechanism, and Therapeutic Approach. Biomedicine & Pharmacotherapy, 129, Article ID: 110385. [Google Scholar] [CrossRef] [PubMed]
[38] Morishita, Y., Yoshizawa, H., Watanabe, M., et al. (2016) MicroRNA Expression Profiling in Peritoneal Fibrosis. Translational Research, 169, 47-66. [Google Scholar] [CrossRef] [PubMed]
[39] Gao, Q., Xu, L., Yang, Q., et al. (2019) MicroRNA-21 Contributes to High Glucose-Induced Fibrosis in Peritoneal Mesothelial Cells in Rat Models by Activation of the Ras-MAPK Signaling Pathway via Sprouty-1. Journal of Cellular Physiology, 234, 5915-5925. [Google Scholar] [CrossRef] [PubMed]
[40] Yang, L., Fan, Y., Zhang, X., et al. (2018) Role of miRNA-21/PTEN on the High Glucose-Induced EMT in Human Mesothelial Peritoneal Cells. American Journal of Translational Research, 10, 2590-2599.
[41] Ma, Y.L., Chen, F., Yang, S.X., et al. (2020) [Retracted] MicroRNA-21 Promotes the Progression of Peritoneal Fibrosis through the Activation of the TGF-β/Smad Signaling Pathway: An in Vitro and in Vivo Study. International Journal of Molecular Medicine, 45, 1627. [Google Scholar] [CrossRef] [PubMed]
[42] Liu, H., Zhang, N. and Tian, D. (2014) MiR-30b Is Involved in Methylglyoxal-Induced Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells in Rats. Cellular & Molecular Biology Letters, 19, 315-329. [Google Scholar] [CrossRef] [PubMed]
[43] Sun, J. and Stathopoulos, A. (2018) FGF Controls Epithelial-Mesenchymal Transitions during Gastrulation by Regulating Cell Division and Apicobasal Polarity. Development, 145, dev161927. [Google Scholar] [CrossRef] [PubMed]
[44] Wu, J., Huang, Q., Li, P., et al. (2019) MicroRNA-145 Promotes the Epithelial-Mesenchymal Transition in Peritoneal Dialysis-Associated Fibrosis by Suppressing Fibroblast Growth Factor 10. Journal of Biological Chemistry, 294, 15052-15067. [Google Scholar] [CrossRef] 
[45] Zhang, Y., Sun, Q., Li, X., et al. (2018) Apigenin Suppresses Mouse Peritoneal Fibrosis by Down-Regulating miR34a Expression. Biomedicine & Pharmacotherapy, 106, 373-380. [Google Scholar] [CrossRef] [PubMed]
[46] Che, M., Shi, T., Feng, S., et al. (2017) The MicroRNA-199a/214 Cluster Targets E-Cadherin and Claudin-2 and Promotes High Glucose-Induced Peritoneal Fibrosis. Journal of the American Society of Nephrology, 28, 2459-2471. [Google Scholar] [CrossRef] 
[47] Liu, Y., Ma, Z., Huang, Z., et al. (2022) MiR-122-5p Promotes Peritoneal Fibrosis in a Rat Model of Peritoneal Dialysis by Targeting Smad5 to Activate Wnt/β-Catenin Pathway. Renal Failure, 44, 191-203. [Google Scholar] [CrossRef] 
[48] Li, J., Li, S.X., Gao, X.H., et al. (2019) HIF1A and VEGF Regulate Each Other by Competing Endogenous RNA Mechanism and Involve in the Pathogenesis of Peritoneal Fibrosis. Pathology Research and Practice, 215, 644-652. [Google Scholar] [CrossRef] [PubMed]
[49] He, Q., Wen, L., Wang, L., et al. (2020) miR-15a-5p Suppresses Peritoneal Fibrosis Induced by Peritoneal Dialysis via Targeting VEGF in Rats. Renal Failure, 42, 932-943. [Google Scholar] [CrossRef] 
[50] Li, X., Liu, H., Sun, L., et al. (2019) MicroRNA-302c Modulates Peritoneal Dialysis-Associated Fibrosis by Targeting Connective Tissue Growth Factor. Journal of Cellular and Molecular Medicine, 23, 2372-2383. [Google Scholar] [CrossRef] [PubMed]
[51] Peinado, H., Olmeda, D. and Cano, A. (2007) Snail, Zeb and bHLH Factors in Tumour Progression: An Alliance against the Epithelial Phenotype? Nature Reviews Cancer, 7, 415-428. [Google Scholar] [CrossRef] [PubMed]
[52] Guo, R., Hao, G., Bao, Y., et al. (2018) MiR-200a Negatively Regulates TGF-β(1)-Induced Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells by Targeting ZEB1/2 Expression. American Journal of Physiology-Renal Physiology, 314, F1087-F1095. [Google Scholar] [CrossRef] [PubMed]
[53] Wei, X., Bao, Y., Zhan, X., et al. (2019) MiR-200a Ameliorates Peritoneal Fibrosis and Functional Deterioration in a Rat Model of Peritoneal Dialysis. International Urology and Nephrology, 51, 889-896. [Google Scholar] [CrossRef] [PubMed]
[54] Chu, J.Y.S., Chau, M.K.M., Chan, C.C.Y., et al. (2019) miR-200c Prevents TGF-β1-Induced Epithelial-to-Mesenchymal Transition and Fibrogenesis in Mesothelial Cells by Targeting ZEB2 and Notch1. Molecular Therapy Nucleic Acids, 17, 78-91. [Google Scholar] [CrossRef] [PubMed]
[55] Zhou, Q., Yang, M., Lan, H., et al. (2013) miR-30a Negatively Regulates TGF-β1-Induced Epithelial-Mesenchymal Transition and Peritoneal Fibrosis by Targeting Snai1. The American Journal of Pathology, 183, 808-819. [Google Scholar] [CrossRef] [PubMed]
[56] Wang, Z., Zhou, Z., Ji, W., et al. (2020) Silencing of lncRNA 6030408B16RIK Prevents Ultrafiltration Failure in Peritoneal Dialysis via microRNA-326-3p-Mediated WISP2 Down-Regulation. Biochemical Journal, 477, 1907-1921. [Google Scholar] [CrossRef] 
[57] Wei, X., Huang, H., Bao, Y., et al. (2019) Novel Long Non-Coding RNA AV310809 Promotes TGF-β1 Induced Epithelial-Mesenchymal Transition of Human Peritoneal Mesothelial Cells via Activation of the Wnt2/β-Catenin Signaling Pathway. Biochemical and Biophysical Research Communications, 513, 119-126. [Google Scholar] [CrossRef] [PubMed]
[58] Zhang, X.W., Wang, L. and Ding, H. (2019) Long Noncoding RNA AK089579 Inhibits Epithelial-to-Mesenchymal Transition of Peritoneal Mesothelial Cells by Competitively Binding to microRNA-296-3p via DOK2 in Peritoneal Fibrosis. The FASEB Journal, 33, 5112-5125. [Google Scholar] [CrossRef] 
[59] Fan, Y., Zhao, X., Ma, J., et al. (2021) LncRNA GAS5 Competitively Combined with miR-21 Regulates PTEN and Influences EMT of Peritoneal Mesothelial Cells via Wnt/β-Catenin Signaling Pathway. Frontiers in Physiology, 12, Article ID: 654951. [Google Scholar] [CrossRef] [PubMed]

为你推荐